MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Phosphorylation by GSK-3β enhances binding of metal ion induced tau oligomers to neutral lipid surfaces

G.S. Nuebling, E. Plesch, T. Högen, S. Lorenzl, F. Kamp, A. Giese (Munich, Germany)

Meeting: 2016 International Congress

Abstract Number: 895

Keywords: Iron, Kinase, Neurofibrillary tangles(NFT), Tauopathies

Session Information

Date: Tuesday, June 21, 2016

Session Title: Pathophysiology (other movement disorders)

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To dissect the complex interplay of tau hyperphosphorylation, metal ion induced oligomer formation and membrane interactions applying single particle fluorescence techniques.

Background: Fibrillar deposits of protein tau are a key hallmark of several neurodegenerative diseases. A mounting body of evidence points towards a complex interplay of different factors such as phosphorylation and metal ions in the formation of small tau oligomers. These oligomers are likely to be a key neurotoxic aggregate species in tauopathies. Furthermore, tau-membrane interactions have recently come into focus as a potential mode of action of tau toxicity.

Methods: We investigated interactions of human recombinant tau and alpha-synuclein (asyn) monomers and Fe3+/Al3+-induced oligomers with small unilamellar vesicles (SUV) derived from 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and dipalmitoylphosphatidylcholine (DPPC) as well as the influence of GSK-3β-mediated tau phosphorylation. Applying single-particle fluorescence techniques, protein-membrane interactions were observed at nanomolar protein concentrations at the single particle level.

Results: Tau monomers show no binding to neutral lipid surfaces irrespective of their phosphorylation state, whereas asyn binding depends on surface configuration. Asyn monomer was observed only to bind to gel-state membranes. In contrast, metal ion induced tau oligomers show a gain of function in binding to neutral lipid surfaces, reminiscent of effects described for asyn earlier. Of note, tau phosphorylation by GSK-3β increases both oligomer formation and membrane affinity of the resulting oligomers.

Conclusions: Our data imply a potential synergistic role of metal-ion induced tau oligomer formation and tau hyperphosphorylation in fostering protein-membrane interactions. Similar effects seen in metal ion induced asyn oligomers point towards a common pathological mechanism of tauopathies and synucleinopathies. The high binding affinity of these oligomers may result in membrane disruption, or may pose a potential means of transcellular transfer of tau pathology.

To cite this abstract in AMA style:

G.S. Nuebling, E. Plesch, T. Högen, S. Lorenzl, F. Kamp, A. Giese. Phosphorylation by GSK-3β enhances binding of metal ion induced tau oligomers to neutral lipid surfaces [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/phosphorylation-by-gsk-3-enhances-binding-of-metal-ion-induced-tau-oligomers-to-neutral-lipid-surfaces/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/phosphorylation-by-gsk-3-enhances-binding-of-metal-ion-induced-tau-oligomers-to-neutral-lipid-surfaces/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley